Ureteral Stents Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The global ureteral stents market encompasses a range of medical devices designed to ensure unobstructed urinary drainage from the renal pelvis to the bladder. Products vary by material composition, including polymer-based stents such as polyurethane, silicone, and hydromer-coated variants, each offering distinct biocompatibility and patency profiles. The market's valuation at $0.53 billion in 2025 reflects established demand across both developed and emerging healthcare systems, with steady adoption fueled by procedural volumes in urology departments globally.

• •Market size estimated at $0.53 billion in 2025 with a projected 5.9% annual growth rate
• •Key product types include polymer-based stents with varying biocompatibility and duration profiles
• •Primary clinical applications include post-lithotripsy drainage, ureteric obstruction management, and post-surgical stenting

Rising prevalence of urolithiasis (kidney stones) globally stands as the primary demand driver, with epidemiological studies indicating increasing incidence linked to dietary and lifestyle factors. Technological advancements in stent design, including drug-eluting and bioabsorbable variants, are expanding clinical utility and patient comfort, encouraging broader physician adoption. Additionally, expanding access to minimally invasive urological procedures in emerging markets and growing healthcare expenditure are supporting sustained market expansion.

• •Growing global incidence of kidney stones and urological disorders
• •Technological innovation in stent materials, including coated and bioabsorbable designs
• •Rising adoption of minimally invasive urological procedures and expanding healthcare access in emerging economies

The market is segmented by material type, including silicone, polyurethane, and other polymer-based stents, as well as by end-use application spanning hospitals, ambulatory surgical centers, and specialty urology clinics. Geographically, North America holds a significant share driven by advanced healthcare infrastructure and high procedural volumes, while the Asia-Pacific region is expected to register the fastest growth due to rising disease burden, improving healthcare access, and growing medical tourism in countries such as India, China, and Southeast Asian nations.

• •North America leads in market share, supported by high urological procedure volumes and advanced healthcare systems
• •Asia-Pacific is the fastest-growing region due to rising prevalence of urological conditions and expanding healthcare infrastructure
• •Europe maintains a steady market presence, with Western Europe driving most demand

What are the recent trends and outlook?

Emerging trends point toward increased adoption of drug-eluting and anti-encrustation-coated stents designed to reduce complications such as encrustation, infection, and patient discomfort. Digital health integration, including stent tracking and patient monitoring technologies, is beginning to influence clinical practice patterns. Over the forecast horizon, the market is expected to maintain a robust growth trajectory, with innovation in bioabsorbable stent technology and expanding indications for ureteral stenting presenting significant opportunities for manufacturers.

• •Growing preference for hydrophilic-coated and drug-eluting stents to minimize patient discomfort and complications
• •Research into bioabsorbable stents that eliminate the need for retrieval procedures
• •Emerging opportunities in value-based care models and digital urology platforms